We solve your problems
If there’s one thing that our decades of experience in optimised strain breeding and genomics have taught us, it’s how to solve problems. We’ve almost certainly dealt with the technical issues and manufacturing headaches that you might be experiencing. Insufficient titre, yield losses, plasmid instability, post-translation modifications, excessive purification steps, toxic processing reagents and waste chemicals, immunogenicity issues, or inconsistent quality or quantity. The list goes on, but in every case we are able to help – thanks to many years of hard-won expertise.
Our partners trust us to help them
We already have a track record of developing swift and validated solutions that organisations like the Bill & Melinda Gates Foundation have deployed to tackle big problems that many assume could not be fixed. One outcome of our involvement is more accessible vaccines.
What we can do for you
We don’t promise the earth. But our decades of expertise in recombinant protein manufacture and genomic research have taught us what can go wrong on the ground, and how to fix it in a way that delivers the outcomes you require over the long term. This enables us to supply optimised processes for recombinant proteins that have the quality consistency, scalability and competitive cost of manufacture to deliver your commercial objectives.
What happens next
If you make contact below, we’ll set up a discovery call with our team. Together we’ll evaluate your project’s commercial objectives and the technical challenges you might be experiencing. This will lead to developing an understanding of the exact characteristics of the recombinant protein and markets that you are dealing with, enabling us to match what you need with what our QTL technology can deliver.
The good news is that the optimised strains we provide will be patent protected and licensed. A staged programme for delivery will be agreed upon before contracting, as will all fees and licensing terms.
